Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Disease Progression and MDM2[original query] |
---|
p53 pathway gene single nucleotide polymorphisms and chronic lymphocytic leukemia. Cancer genetics and cytogenetics 2007 Nov 179 (1): 36-44. Lahiri Onoshua, Harris Scott, Packham Graham, Howell Melan |
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Annals of surgical oncology 2009 Feb 16 (2): 431-9. Chen Jinyun, Li Donghui, Killary Ann M, Sen Subrata, Amos Christopher I, Evans Douglas B, Abbruzzese James L, Frazier Marsha |
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma. European journal of cancer (Oxford, England : 1990) 2008 Nov 44 (17): 2634-9. Perfumo C, Parodi S, Mazzocco K, Defferrari R, Inga A, Haupt R, Fronza G, Tonini G |
MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia. European journal of haematology 2010 Sep 85 (3): 251-6. Willander Kerstin, Ungerbäck Jonas, Karlsson Karin, Fredrikson Mats, Söderkvist Peter, Linderholm Ma |
Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma. Pediatric blood & cancer 2012 Jul 59 (1): 39-43. de Oliveira Reis Adriana Helena, de Carvalho Ivna Néria Silva Ribamar, de Sousa Damasceno Paula Batista, Ferman Sima Esther, Lucena Evandro, Lopez-Camelo Jorge Santiago, Seuánez Héctor N, Vargas Fernando Reg |
Lack of association between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndrome. Neoplasma 2012 59 (5): 530-5. Machado-Neto J A, Traina F, De Melo Campos P, Andreoli-Risso M F, Costa F F, Olalla Saad S |
Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma. Oncology reports 2014 Jan 31 (1): 223-31. Xie Xiaoxue, Jin Hekun, Hu Jun, Zeng Yong, Zhou Jumei, Ouyang Shuyu, Yang Wenjuan, Hu Bingqiang, Wang H |
Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma. PloS one 2015 10 (3): e0118829. Hori Yasuki, Miyabe Katsuyuki, Yoshida Michihiro, Nakazawa Takahiro, Hayashi Kazuki, Naitoh Itaru, Shimizu Shuya, Kondo Hiromu, Nishi Yuji, Umemura Shuichiro, Kato Akihisa, Ohara Hirotaka, Inagaki Hiroshi, Joh Takas |
Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Nov . Yadav P, Masroor M, Tanwer K, Mir R, Javid J, Ahmad I, Zuberi M, Kaza R C M, Jain S K, Khurana N, Ray P C, Saxena |
Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy. Bulletin of experimental biology and medicine 2020 Aug 169 (4): 486-490. Zavarykina T M, Tyulyandina A S, Khokhlova S V, Khabas G N, Asaturova A V, Nosova Yu A, Brenner P K, Kapralova M A, Atkarskaya M V, Khodyrev D S, Burdennyi A M, Loginov V I, Stenina M B, Sukhikh G |
Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin. Blood advances 2020 11 4 (22): 5735-5744. Marcellino Bridget K, Farnoud Noushin, Cassinat Bruno, Lu Min, Verger Emanuelle, McGovern Erin, Patel Minal, Medina-Martinez Juan, Levine Max Fine, Arango Ossa Juanes E, Zhou Yangyu, Kosiorek Heidi, Mehrotra Meenakshi, Houldsworth Jane, Dueck Amylou, Rossi Michael, Mascarenhas John, Kiladjian Jean-Jacques, Rampal Raajit K, Hoffman Rona |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: